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Summary 
The ability of B cells or macrophages and dendritic cells (DC) to elicit class II-restricted T cell 
responses in vivo was compared using a mouse chimera model. Severe combined immunodeficient 
(SCID) mice (H-2a),  reconstituted either with T  or T+B lymphocytes from (H-2  a  x  H-2  b) 
donors, were immunized subcutaneously with protein antigen (Ag) to induce a class II-restricted 
T cell response. The frequency and major histocompatibility complex restriction of the resulting 
Ag-specific T cells were analyzed to establish  whether B cells were necessary for the induction 
of class II-restricted T cell responses, and to determine the cell type on which priming had occurred. 
The results indicated that: (a) B cells are not necessary for the induction of a class II-restricted 
T cell response in vivo, as the frequencies ofinterleukin 2 (IL-2)- or IL-3-secreting T cells induced 
in the presence or absence of B cells were comparable. (b) Activation of naive T cells requires 
presentation of Ag on DC; Ag presented only on B cells is not sufficient to elicit a response. 
No H-2b-restricted, IL-3-secreting cells could in fact be detected in SCID mice reconstituted 
with naive (H-2  a  ￿  H-2  b) T  cells and nonimmune or antigen-primed (H-2  a  ￿  H-2  b) B cells. 
(c) Previously primed T cells are able to be stimulated by Ag presented by both B cells and DC. 
H-2b-restricted, II.-3-secreting cells could in fact be readily demonstrated in SCID mice recon- 
stituted with antigen-primed (H-2  ~ ￿  H-2  b) T  and B cells. Irrespective of whether the T cells 
were naive or previously activated, B cells were able to respond with an Ag-specific immunoglobulin 
G response, indicating that B cells were functional and able to present Ag in order to receive 
specific T  cell help.  Therefore, it appears  that B cells are not necessary and do not participate 
in the initial priming ofT cells; however, Ag presented by B cells can reactivate previously primed 
T  cells. Taken together, these data indicate that during the course of an immune response Ag 
is first presented to naive T cells via DC, and only subsequently primed T cells can be stimulated 
by Ag presented by B cells. 
T 
he mechanisms by which APC take up,  degrade, and 
reexpress processed Ag at the cell surface in association 
with class II MHC molecules are being increasingly clarified 
(reviewed in reference 1). However, despite considerable prog- 
ress in defining the process at the cellular level, the identity 
of the cells that stimulate T cells in vivo is still unclear. Sev- 
eral cell populations have the properties required to be potential 
in vivo APC, but evidence concerning their role in different 
steps of the immune response, or in response to Ag entering 
the organism in different forms, or via different routes, is 
still incomplete. This question is of considerable importance, 
as different APC may be able to regulate the immune response 
in a positive or negative fashion by delivering opposing signals 
to the T cells (2). Moreover, different APC express different 
accessory molecules (3), and may be able to induce different 
functions (e.g.,  secretion of different sets  of lymphokines) 
in the responding T  cells  (4,  5). 
A  considerable number of in vitro studies show that B 
ceils are potent APC for T  cells (reviewed in reference 6), 
being able to use their surface Ig to take up Ag present in 
very low amounts in the medium (7, 8), internalize it, and 
process it so it can be presented (9). Less is known concerning 
the ability of B cells to stimulate T  cell responses in vivo 
(10). Evidence in favor of B cell involvement in T  cell re- 
sponses in vivo comes from experiments performed by different 
groups using mice treated from birth with anti-/* antibodies 
(11-15).  These animals show a virtually complete block of 
the development of B cells, and are unable to mount T  cell 
proliferative responses to Ag administered subcutaneously 
(11-14). Local administration of B cells can reconstitute the 
response (14, 16), suggesting that B cells are required for the 
generation of a T  cell response. In apparent contrast with 
these findings, Lassila et al. (17) used a chicken chimeTa model 
to show that antibody responses to SRBC could only be gener- 
ated in the presence of spleen cells (as a source of "profes- 
sional" APC) that were MHC matched with the B cells. This 
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initiation of a T cell response. Several reasons could account 
for the apparent discrepancy between these two sets of data: 
the method of assessment  (T vs. B cell responses),  and the 
type and location of Ag challenge (different kinds of Ag and 
different lymphoid organs involved). 
An experimental model was therefore designed that makes 
use of SCID mice to study the role of B cells vs. dendritic 
cells (DC) t in the induction of a T  cell immune response. 
SCID mice are unable to generate normal T  or B cells due 
to a recombinase defect that prevents  successful rearrange- 
ment of the Ig and TCR loci (18, 19), but does not affect 
the development or function of DC (20,  21). SCID mice 
(H-2  a, BALB/c background) were reconstituted with ma- 
ture T or T+B cells from semiallogeneic (BALB/c  x  B6)F1 
(H-2  a  x  H-2  b) donors, and immunized with Ag in adju- 
vant in order to induce a T cell response.  The contribution 
of B cells (or their products) could be examined in these mice 
by comparing T cell responses in animals reconstituted with 
or without B cells. Also, analysis of the MHC restriction 
of Ag-specific T cells in animals reconstituted with T+ B cells 
shows whether the T cells have been primed on DC (of host 
origin; H-2a),  in which case the whole response  should be 
H-2  d restricted,  or on B  cells (of donor origin;  H-2  d  x 
H-2b), in which case the response  should be at least in part 
H-2  b restricted.  The results described here show that B cells 
are not necessary for the induction of a T cell response,  and 
are in fact unable to prime naive T cells. They are, however, 
able to reactivate previously primed T cells, indicating a role 
for B cells in presenting antigen in secondary responses. 
Materials and Methods 
Mice.  C.B-17/Icr scid/scid (SCID; Igh-1  b congenic BALB/c) 
mice were bred at the Basel Institute for Immunology (BII) from 
breeding pairs obtained through the courtesy of Dr. M. Bosma 
(Fox Chase Cancer Institute, Philadelphia, PA). Mice of '-12 wk 
of age were tested before reconstitution for leakiness of the SCID 
phenotype by evaluating serum IgM and IgG titers in Ouchter- 
lony assay or ELISA. (BALB/c x  B6)F1 mice (cB6) were bred at 
the BII or obtained from Bomholtg~rd (ILy, Denmark). BALB/c 
nu/nu were from Iffa Credo (L'Arbresle, France); C57BL/6 (B6) 
nu/nu were from Bomholtg~rd. 
Antigens.  OVA (grade V) was purchased from Sigma Chem- 
ical Co. (St. Louis, MO); KLH was purchased from Calbiochem- 
Behring Corp. (La Jolla, CA). Coupling of DNP to protein was 
performed  by incubating the protein solution in 0.1 M borate buffer 
with 2,4-dinitrofluorobenzene  (2,4 DNFB) (Sigma Chemical Co.) 
at 37~  for a few minutes; unbound DNFB was removed  by dial- 
ysis. The degree of haptenization was calculated from absorbance 
values at 280 and 360 nm as described (22). 
|  n  Antibodies and FACS  Analysis.  The mouse mAbs Y-3P (a  ti- 
I-Ab'k;  23), MK-D6 (anti-I-Ad; 24), 14-4-4S (anti-I-Ed'k'b; 25), 
RS-3.1 (anti-Igh-6a; 26), and MARK-1 (mouse anti-rat k, 27), 
and the hamster mAb 2Cll (anti-CD3; 28) were purified on the 
Afft-Gel  protein A MAPS II kit (Bio-Rad  Laboratories,  Richmond, 
CA) from culture supernatants according to the manufacturer's in- 
1  Abbreviation used in this paper: DC, dendritic  cell. 
structions. The rat mAbs GK1.5 (anti-CD4; 29), 2.43 (anti-CD8.2; 
30), 6B2 (anti-B220; 31), F4/80 (anti-macrophage;  32), and 2.4G2 
(anti-F~ receptor; 33) were affinity purified from culture super- 
natants on protein G-Sepharose (Pharmacia  LKB,  Uppsala, Sweden). 
The IgM mAbs  J11d (rat, anti-HSA; 34) and 28-13-3S (mouse, anti- 
KS; 35) were purified from culture supernatants by 40% ammo- 
nium sulphate precipitation and dialysis  against 5 mM phosphate 
buffer; the  precipitate was  collected by centrifugation  and re- 
suspended in PBS. FITC labeling and biotinylation were performed 
as described (36). Second-step reagents (goat anti-mouse Ig-FITC, 
goat anti-mouse IgG-PE, goat anti-mouse IgM-PE, Streptavidin- 
FITC, Streptavidin-PE)  were from Jackson ImmunoResearch  Labs, 
Inc., West Grove, PA). Stainings were performed on 2-5  x  105 
RBC-depleted cells in 100/zl PBS +  2% FCS in U-bottomed 96- 
well plates (Dynatech Labs, Embrach, Switzerland) for 10 min on 
ice. Optimal antibody concentrations were determined experimen- 
tally and ranged between 0.25 and 1 #g/well; the anti-Fc2/K  mAb 
2.4G2 was used to inhibit nonspecific  staining. Analysis was per- 
formed on a FACScan  |  (Becton  Dickinson & Co., Mountain View, 
CA). Instrument compensation was set in each experiment using 
samples stained with single-color reagents. 
Reconstitution of SCID Mice.  Nonirradiated SCID mice were 
reconstituted  by intravenous  injection  in the lateral  tail vein of  20-70 
x  106 sex-matched purified T or T+B cells in PBS; the number 
of T cells in the inoculum was maintained constant in each experi- 
ment. For all mice, reconstitution of the peripheral lymphoid organs 
was tested at the time of death by fluorescent staining of thymus, 
lymph node, and spleen cell suspensions with H-2  b- and Igh  ~- 
specific reagents. 
Splenic cB6 T or T + B Cells.  For transfer  into SCID mice, splenic 
cB6 T or T+B cells were prepared as follows. Mechanically dis- 
rupted spleen cell suspensions were fractionated by centrifugation 
on Percoll (Pharmacia  LKB) gradients to deplete low density DC; 
the dense 60-70% fraction (0 =  1.076-1.088 g/ml) was collected. 
B cells were depleted by incubation with sheep anti-mouse IgG- 
coated Dynabeads (Dynal, Oslo, Norway) and magnetic adherence. 
The injected population contained between 40 and 60% T cells 
in different experiments; after B cell depletion the percentage of 
B220 § cells was <1%. 
Naive  T  Cells.  These were prepared from the thymuses of 
4-wk-old cB6 donor mice (37) by depletion with Jlld mAb and 
magnetic beads. Briefly,  thymus cell suspensions were adjusted at 
-~2  x  107  cells/ml, incubated in  purified Jlld  (10  #g/ml) in 
medium for 30 min on ice, washed, incubated in a cocktail of 
MARK-l, Y-3P, 14-4-4S mAbs (each 10/~g/ml) for 30 min on ice, 
washed, incubated with sheep anti-mouse IgG-coated Dynabeads 
(Dynal) for 30 min at 4~  with constant rocking, and depleted 
by two rounds of magnetic adherence. The treatment was repeated 
until a satisfactory  depletion was achieved.  Typically,  the resulting 
T cell population was 80-85%  CD4 or CD8 single positive and 
70-75%  CD3 high. 
Normal orAg-primedB Cells.  These  were prepared as described 
above from the spleens of nonimmune cB6 mice, or cB6 mice im- 
munized 4-6 wk previously  by intraperitoneal injection of 100/xg 
OVA-DNP in alum. T cells were depleted by magnetic sorting by 
incubation in a cocktail of purified GK1.5 (anti CD4) and 2.43 
(anti CDf) at 10/~g/ml,  and sheep anti-rat Dynabeads (Dynal) 
in the presence of 1% BALB/c normal serum. The resulting popu- 
lation was 80-85%  B220  +. 
Ag-primed  T  and B  Cells.  These  were prepared from the pe- 
ripheral lymph nodes of cB6 mice immunized subcutaneously on 
the back and two flanks 3 wk previously  with 100/~g KLH-DNP 
in alum. Mechanically  disrupted lymph node cell suspensions  were 
680  Antigen  Presentation by B Calls In Vivo depleted of low density DC by two rounds of centrifugation on 
50% Percoll; the dense fraction was recovered. Part of the resulting 
population  was  depleted of B cells by incubation  with sheep 
anti-mouse Dynabeads.  On average the resulting populations were 
<1% F4/80 +, 65-74%  CD3 +, and 24-35%  sIg +. After B cell 
depletion, contamination by B220  + cells was <1%.  The trans- 
ferred population was tested for the presence of Ag-specific T cells 
by assaying  the frequency  of Ib3-producing cells in a limiting dilu- 
tion assay in vitro. 
Immunizations.  Mice  were immunized 1-3 d after reconstitu- 
tion by injection with 100 #g (or as otherwise indicated) KLH 
or KLH-DNP or 200/~g OVA in alum precipitate (Serva, Heidel- 
berg, Germany)  subcutaneously  in the back and two flanks.  Animals 
were killed 7-12 d after immunization, bled by cardiac puncture, 
and analyzed for T cell responsiveness by in vitro culture. 
Tissue Culture Medium and Factors.  All cultures were in IMDM 
supplemented with 2 mM glutamine (Gibco, Paisley, Scotland), 
1% Penicillin-streptomycin  (Gibco), 5  x  10 -s M 2-ME (Sigma 
Chemical Co.), and 10% FCS (Boehringer  Mannheim, Mannheim, 
Germany). Human rIL-2 (Hoffman-La  Roche, Nutley, NJ) was ob- 
tained through the courtesy of Dr. F. Sinigaglia (Hoffmann-La 
Roche & Co., Ltd., Basel, Switzerland). Mouse IL-3 was obtained 
through  the  courtesy of Dr.  G.  Le Gros (Ciba-Geigy, Basel, 
Switzerland). 
11-,2 Limiting Dilution Assays.  A modification of the method 
of Rocha and Bandeira (38) was used to determine the frequency 
of  Ib2-producing, Ag-specific  cells. Briefly,  mouse peripheral lymph 
nodes and spleens were aseptically removed, mashed by gently 
forcing through a nylon sieve, and resuspended  in medium by pipet- 
ting. Graded numbers of total lymph node cell suspensions were 
plated on 3  x  104 cB6 irradiated (2,000 rad) spleen cells plus or 
minus Ag (OVA, 200 #g/ml; or KLH, 50 #g/ml) in U-bottomed 
96-well plates (Costar, Cambridge, MA) in a total volume of 40 
#1, Between 21 and 28 wells were plated for each cell concentra- 
tion; 12 control wells (no responder cells) were set up in each ex- 
perimental plate. After incubation at 37~  for 36-40 h, the plates 
were irradiated (2,000 tad), 50 HT-2 Ib2-dependent cells (39) were 
added to each well in a volume of 10 gl, and incubation was con- 
tinued for another 48 h. "Rescue" II~2 (100 #l/we[i,  100 U/ml) 
was then added to all wells, and incubation continued for 4 d; 
labeling with [3H]TdR (5Ci/mmol, l#Ci/well; Amersham Corp., 
Arlington Heights, IL) was performed in the last 6 h of culture. 
Individual microcultures were scored as positive or negative based 
on the incorporations determined on control wells. Regression 
curves were constructed by plotting the number of responder cells 
per well versus the log of the percentage of negative wells; only 
experiments in which regression coefficient (R) > 0.9 were con- 
sidered. Frequencies were calculated  on the regression curve by in- 
terpolating the number of responder cells required to give 37% 
negative cultures (corresponding to one precursor/well according 
to Poisson statistics). Data analysis  using the least square and max- 
imum likelihood  methods gave  comparable  results. Because  the per- 
centages ofT cells in lymph nodes of  different  groups of  mice varied 
less than twofold, data are presented as frequencies  per total lymph 
node cells. 
11.,3 Limiting Dilution Assay.  A modification of the IIr  lim- 
iting dilution assay  was used. Cultures were set up in the presence 
of 10 U rlL-2/ml; after incubation for 72 h at 37~  the plates were 
irradiated, 80 FD/C.1 IL-3-dependent  cells (40) were added to each 
well in 10 gl volume, and the incubation was continued for 4 d. 
[3H]TdR pulse was in the last 6 h of the assay. 
Determination of the MHC Restriction of  lndividual Clones.  0.5-2 
x  106 lymph node cells from KLH-immunized mice were cul- 
tured in 24-well plates (Costar) in the presence of 4  x  106 irradi- 
ated cB6 spleen ceils and 50 #g/ml KLH in a total volume of 1.5 
ml in order to expand Ag-spocific calls. Culture of lymph node 
calls from nonimmunized mice did not result in detectable cell 
growth. After 8-10 d of culture, cells were harvested, centrifuged 
on lympholyte-M (Cedarlane Laboratories, Ontario, Canada) to 
remove dead cells, and plated at limiting numbers on 3  x  104 ir- 
radiated cB6 feeder calls with 50 gg/ml KLH and 10 U/ml Ib2 
in a total volume of 80 gl in U-bottomed 96-well plates. After 10 
d microcultures seeded with optimal numbers of T cells as deter- 
mined by microscopical examination were centrifuged on a plate 
carrier, washed twice, and each individual microwell was divided 
into four aliquots. Each aliquot was plated on 5  x  104 BALB/c 
nu/nu or C57BL/6 nu/nu irradiated feeder cells in the presence of 
10 U/ml Ib2, with or without 50 #g/ml KLH, in a final volume 
of 50 #1. IL-3 production in individual wells was determined by 
proliferation of the IL-3-dependent cell line FD/C.1 as described 
above. Wells  where IL-3  production (as measured  by FD/C.1 prolifer- 
ation) in the absence of  specific  antigen exr.eeded  20% of  the prolifer- 
ation in the presence of antigen were excluded. 
ELISAs.  Ag-specific  and total Ig responses were determined 
in a sandwich ELISA by incubating twofold test serum dilutions 
on ELISA  plates (Dynatech) coated with 10/~g OVA-DNP or KLH 
per well, or 1 #g goat anti-mouse Ig per well (Southern Biotech- 
nology Associates, Birmingham, AL), respectively. The reaction 
was developed  by the addition of  0.2 #g/ml isotype-specific  horse- 
radish Peroxidase-conjugated  goat anti-mouse IgG or IgM (Southern 
Biotechnology  Associates) and  1  mg/ml  O-phenylenediamine 
(Sigma Chemical Co.) substrate; 2 M H2SO4 was added to stop 
the  reaction.  Optical  densities were  measured on  a  Titertek 
Multiskan  |  MCC/340  ELISA reader (Flow Laboratories AG, 
Allschwil, Switzerland). 
Results 
SCID Mice  Can Be Reconstituted  with Normal  T  and B 
Cells.  Preliminary experiments were performed in which 
SCID mice were reconstituted with spleen or lymph node 
cell  suspensions  from (BALB/c  x  B6)F1 (cB6)  mice, and 
analyzed at different times after injection for homing and per- 
sistence  of the injected T  and B cells. The results demon- 
strated that donor T  and B cells could home to the spleen 
and lymph nodes of SCID mice and reconstitute a morpho- 
logically normal lymphoid structure (B. Scott, F. Ronchese, 
and M. Kosco, unpublished results).  At a population level, 
injected cells could persist in the host for a significant length 
of time (3 mo was the maximum time analyzed) without 
significant alterations in total cell number or in phenotype 
(CD4/CD8  ratios,  percent IgM + or Lyl  + B cells).  These 
results are in complete agreement with those reported by 
Sprent et al.  (41). 
Consistent with the lack of any significant expansion of 
the  number  of T  cells  transferred  into  SCID  mice,  no 
significant increase in the frequency of IL-2-producing, au- 
toreactive T cells could be detected in SCID mice reconstituted 
with cB6 T or T+B cells 1, 3, or 5 wk before analysis (data 
not shown). These data indicate that cB6 cells injected into 
SCID mice do not undergo gross alterations in distribution, 
number, or reactivity, and can be considered to reflect  the 
peripheral repertoire of a normal mouse. Therefore, SCID 
mice reconstituted with cB6 T or T+B cells can be used as 
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cell responses in vivo. 
B Cells Are Not Necessary  for the Induction ofa T Cell Re- 
sponse.  SCID mice reconstituted with T or T+ B cells were  100~ 
compared for the ability to generate T  cell responses after  .~ 
subcutaneous  immunization  with  Ag  in  alum  adjuvant.  | 
Nonimmunized spleen suspensions were used as donor cells  .~ 
for transfer into SCID mice as they contain a higher propor-  8'  10  e. 
tion of B cells. T  cell responses in the draining lymph node 
of SCID and control mice were measured by using a limiting 
dilution  assay  to assess the frequency of Ag-specific,  II~2- 
producing cells. This assay was chosen instead of a standard  1 
T  cell proliferation assay because it was considered to mea- 
sure a more meaningful parameter of T  cell function,  such  10oo 
as in vivo clonal expansion and the ability to secrete factors 
involved in proliferation, help, and activation of effector mech- 
anisms.  In addition,  it is more sensitive in detecting T  cell 
responses, and can be performed with a low number of cells.  =  100 
The frequency of IL-2-producing cells in lymph nodes of  | 
SCID mice reconstituted with T or T+ B cells is comparable  .[ 
to the frequency obtained in similarly immunized cB6 mice;  ~  10 
most notably, the frequency of Ag-specific T  cells in mice  .~ 
reconstituted only with T  cells is as high as the frequency 
detected in mice reconstituted with T+B cells  (Fig.  1).  A 
number  of similar  experiments  performed  with  mice im-  1 
munized with KLH or OVA showed comparable results (Table 
1); mice not immunized with Ag in vivo failed to generate  100o 
significant frequencies of Ib2-secreting cells (Table 1). There- 
fore, DC  appear to be sufficient for the induction  of Ag- 
specific,  IL-2-producing T  cells in vivo; B cells  appear not 
to be necessary.  100  _= 
T  cells in the mouse have been functionally divided into 
Thl, producing Ib2, IL,3, IFN~, and L'I~ and Th2, producing  .~ 
II.-3, IL-4, II.-5, II-6, and Ibl0 (42, 43). It was therefore pos-  ~, 
sible that B cells,  although  not involved in the priming  of  --  10 
IL-2-producing T cells, could nonetheless be required for the 
priming and/or expansion of Th2 cells. Also, differences be- 
tween immunization  in the presence or in the absence of B 
cells might be revealed by immunization with limiting doses 
of Ag. To test these possibilities, reconstituted SCID mice 
were immunized with lower amounts of Ag and tested for 
the frequency of Ag-specific,  IL-3-producing cells, as this lym- 
phokine is produced by all functional subsets of Th cells (42). 
Again,  no differences could be detected in the frequencies 
of Ag-specific T  cells elicited in the presence or absence of 
B ceils in these conditions  (Table  1),  or using lower doses 
of Ag (e.g., 3/~g KLH/mouse; not shown) that still elicited 
significant  responses in both groups.  This  argues that  the 
failure to detect a difference between priming in the presence 
or in the absence of B cells was not simply due to the use 
of "saturating"  doses of Ag, or to the exclusion of a sub- 
population ofT cells dependent on B cells for priming and/or 
expansion. Also, no in vivo primed T cells should be missed 
in the in vitro assay used, as it was performed in the presence 
of high numbers of splenic APC, which are able to sustain 
proliferation and lymphokine production by both Thl  and 
Th2 cells  (44,  45). 
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Limiting dilution analysis of the frequencies  of KLH-specific 
Ib2-secreting ceils in SCID mice reconstituted with nonimmune splenic 
T cells or T+ B cells from cB6 mice. Reconstituted SCID mice and cB6 
mice were immunized subcutaneously  with 100/~g  KLH in alum and tested 
for frequency of Ib2-producing cells in the presence (1) or absence (O) 
of specific  antigen 7 d after immunization. Total cell suspensions  prepared 
from the draining lymph nodes were used as effector  populations in the 
limiting dilution assay  without any further purification; T cells  represented 
61% of the total lymph node population in SCID (T) mice, and 50% 
in SCID (T+B) mice. 
Lastly,  the possibilities that  the transferred B cells  were 
either not functionally active in vivo, or failed to interact with 
T cells, were also tested. To this purpose, SCID mice recon- 
stituted with T  or T+ B cells,  and immunized with KLH- 
DNP as above, were bled at the time of death and tested for 
DNP-spedfic serum IgM and IgG in an ELISA (Fig. 2). SCID 
mice that received only T cells failed to generate Ag-specific 
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Experimental group 
Immunizing  Antigen  Lymphokine 
antigen  in culture  tested  SCID (T)  SCID (T + B)  (BALB/c  x  B6)  F1 
OVA*  OVA  IL-2  2,261*  3,751  5,968 
8,495  6,673  4,041 
6,213  4,957 
None  OVA  IL-2  51,457  111,657 
KLH  s  KLH  IL-2  388  333  773 
363  735  1,948 
344  117 
112  176 
None  KLH  IL-2  47,796  23,391  153,660 
KLHII  KLH  IL-3  1,286  1,175 
1,520  1,122 
The frequencies of antigen-specific, lymphokine-producing T ceils  induced by antigen immunization in the presence or in the absence of B cells are 
comparable. SCID mice reconstituted with nonimmune T or T + B spleen cells from cB6 mice were immunized with antigen in alum adjuvant or 
left untreated; peripheral lymph node cell suspensions were tested 7-12 d after immunization for frequencies of IL-2- or IL-3-producing calls in a 
limiting dilution assay. Because the variation in percentages of T cells in lymph nodes from different groups of mice was less than twofold, frequencies 
per total lymph node population are presented. 
* Used at 200/zg/mouse. 
t Reciprocal of frequency estimates as calculated by linear regression; the frequencies of cells producing lymphokine in the absence of antigen are 
subtracted. 
S Used at  100/~g/mouse. 
II Used at  10/zg/mouse. 
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antibody responses, confirming the hck of functional B cells 
in these mice. In contrast,  mice that received both T  and 
B cells generated significant titers of DNP-specific IgG. No 
DNP-specific antibodies were detectable in mice immunized 
with unmodified KLH, demonstrating that the response was 
in fact Ag specific  (Fig. 2). Therefore, B cells in these animals 
are functional and able to take up Ag and receive T call help. 
Thus, failure of B cells to prime T  ceUs cannot be due to 
their functional incompetence or to inability to interact with 
Th ceUs. 
B Cells Cannot Prime Naive T Cells.  To assess the priming 
requirements of naive T cells, cB6 single-positive thymic T 
ceils were transferred into SCID mice in the presence or ab- 
sence of cB6 splenic B cells. Thymic T cells were chosen be- 
Figure 2.  Production of specific  antibodies in SCID mice reconstituted 
with nonimmune splenic T or T+B calls. Reconstituted SCID mice and 
cB6 mice were immunized subcutaneously with 100 #g KI.H-DNP and 
tested for DNP-specific serum IgM and IgG in an ELISA. ([] and O) 
SCID mice reconstituted with T cells  only and immunized with KLH- 
DNP 9 d previously; (.  and O) SCID mice reconstituted with T+B calls 
and immunized with KLH-DNP 9 d previously; (￿  SCID mouse recon- 
stituted with T+B cells and immunized with nonmodified KLH 9 d pre- 
viously; (A) cB6 mouse immunized with KLH-DNP 7 d previously; (A) 
cB6 mouse immunized with KLH-DNP 35 and 7 d previously; (+) cB6 
normal serum. 
683  Konchese  and Hausmann cause of the lack of suitable  surface markers to isolate naive 
T cells from the peripheral repertoire of normal mice. Single- 
positive cells were separated from the bulk of the immature 
thymocyte cell populations by negative  selection with the 
Jlld mAb (34, 46). When transferred into SCID mice these 
cells behaved in a fashion similar  to T  cells from peripheral 
organs in terms of homing and survival  in the host.  SCID 
mice reconstituted with T or T+ B cells were immunized with 
KLH-DNP in alum and killed 9-12 d after immunization. 
Lymph node cell suspensions were cultured on cB6 feeder 
cells in the presence  of specific Ag and subsequently assayed 
for MHC restriction of the responding T cells as described 
in Material  and Methods. 
Fig. 3 shows the results of one such experiment in which 
the Ag-specific activity of individual wells is compared for 
T  cells  from control cB6 mice or from SCID mice recon- 
stituted with T  or T+B cells.  Ag-specific T  cells from cB6 
mice (H-2  d x  H-2  b) fell into two groups:  T  cells that rec- 
ognized Ag in the context of H-2 d (i.e.,  able to recognize 
Ag  on BALB/c  but  not B6  APC),  and  H-2b-restricted  T 
cells  that showed the reciprocal  behavior,  i.e., reactivity to 
Ag plus B6 and not Ag plus BALB/c APC. This implies that 
H-2  a and H-2  b are equally able to present KLH antigen to 
T cells.  Nonetheless, when T cells from SClD mice (H-2  d) 
reconstituted with cB6 (H-2  a  x  H-2  b) T or T+B cells were 
analyzed in this assay, all the Ag-specific activity was restricted 
to H-2d-expressing BALB/c APC regardless of the presence 
or absence in the host of B cells expressing  H-2  b gene prod- 
ucts. Transfer orb cells from mice previously primed to DNP, 
and therefore presumably enriched in DNP-specific B  cells 
(Fig. 3), or of B cells from nonimmune mice, did not affect 
the result  of the experiment. It was possible that the trans- 
ferred B cells might not be functional or able to interact with 
T cells; however, expression of increased levels of class II and 
production of Ag-specific IgG in these mice  (not  shown) 
demonstrated that this was not the case. 
Therefore, naive T cells can only be primed by Ag presented 
on DC, regardless of the presence in vivo of Ag-specific, ac- 
tivated B cells. 
B Cells Can Act as APC to Recall Responses by Previously 
Primed T Cells.  Naive and Ag-experienced T cells have been 
reported to express different levels of adhesion molecules (3) 
and to show different activation requirements in vitro (47-49); 
therefore, they may also show different requirements  in terms 
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Figure  3.  Analysis of the MHC restriction of antigen-specific T cells recovered from immunized SCID mice reconstituted with naive (single-positive 
thymic) T cells or with naive T and splenic B cells from DNP-primed  mice. Each panel corresponds to one mouse; each dot represents antigen-specific 
II.-3 production  of a single microculture as measured by proliferation~of an IL-3-dependent cell line. Reconstituted  SCID mice and cB6  mice were 
immunized subcutaneously with 100 #g KLH-DNP in alum; cells from the draining lymph nodes were cultured on irradiated cB6 feeder cells and 
KLH, and plated into 96-well plates as detailed in Material and Methods.  Individual microwells were subsequently assayed for MHC restriction by 
dividing into four aliquots and testing each aliquot on BALB/c or B6 feeder cells in the presence or absence of KLH; results obtained with two different 
cell inputs/well are pooled in each panel. The percentage of wells giving a response varied between 3 and 60%, and was usually between 10 and 40%. 
Microcultures responding to both parental haplotypes are most likely due to the simultaneous presence of more than one precursor in the same well. 
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Figure 4.  Analysis of the MHC restriction 
of antigen-specific T cells recovered from im- 
munized SCID mice reconstituted with KLH- 
DNP-specific "antigen-e~perienced" T cells or 
with KLH-DNP-specific T and B cells. Each 
panel  corresponds  to  one mouse;  each dot 
represents antigen-specific Ib3 production of 
a single microculture as measured by prolifera- 
tion of an IL-3-dependent cell line.  Recon- 
stituted  SCID  mice  were  immunized sub- 
cutaneously with 100/xg KLH-DNP on alum; 
cells from the draining lymph nodes were cub 
tured on irradiated cB6 feeder cells and KLH, 
:nd phted into 96-wall phtes as detailed in Ma- 
terial and Methods. Individual microwells were 
subsequently assayed for MHC restriction by 
dividing into four aliquots and testing each ali- 
quot on BALB/c or B6 feeder cells in the pres- 
ence or absence of KLH; results obtained with 
two different cell inputs/well are pooled in each 
panel. The percentage  of wells giving a response 
varied between 15 and 85%, and was usually 
between 30 and 60%. Microcuhures responding 
to both parental haplotypes are most likely due 
to the simultaneous presence of more than one 
precursor in the same well. 
of Ag presentation in vivo. To assess whether this is the case, 
Ag-primed T calls were used to reconstitute SCID mice. cB6 
mice that had been immunized subcutaneously with KLH- 
DNP 3 wk previously were used as a source of Ag-primed 
T cells; such T cells are restricted to both the MHC haplo- 
types present  in the donor strain,  H-2  d and H-2  b.  SCID 
mice were reconstituted with lymph node cell suspensions 
that were depleted or not depleted orB cells, and were again 
immunized subcutaneously with KLH-DNP; the restriction 
of  Ag-specific  T cells  recovered  from the draining lymph nodes 
was then analyzed. 
As  shown  in  Fig.  4,  SCID  mice (H-2  a)  that  received 
purified T ceUs from immune cB6 mice showed a response 
exclusively H-2  a restricted;  the H-2b-restricted T  cell sub- 
population was most likely not expanded or not recalled to 
effector phenotype due to the absence in the host of APC 
expressing the appropriate MHC. In contrast, H-2b-restricted 
T  cells were readily demonstrated in SCID  mice that had 
received  both T and B cel]s from immunized  cB6 mice, despite 
the inability  of the assay to detect I-Eb-restricted T  cells. 
Since in these reconstituted SCID mice H-2  b was present 
only on B calls and not on macrophages or DC, we conclude 
that, unlike naive T  calls, Ag-experienced T  cells are able 
to be restimulated  by Ag presented on B cells. 
Discussion 
The present study was aimed at defining the role orb ceUs 
versus other APC in the presentation  of Ag to class II-re- 
stricted T cells in vivo. Two specific questions were asked: 
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are B cells required for priming of T  cells, and are B cells 
able to present Ag directly to T cells in primary and/or sec- 
ondary immune responses? 
To analyze the requirement of B cells for the induction 
of a T cell response, a limiting dilution assay for IL-2- and 
IL-3-producing ceUs was used to evaluate the clonal expan- 
sion of Ag-specific T cells induced by immunization in the 
presence or absence orb cells. The results dearly showed that 
B cells or their products  are not required for the initiation 
of a T cell immune response; presentation of  Ag to class II-re- 
stricted T cells in vivo is carried out preferentially by other 
APC. The precise identity of such a "professional" APC was 
not further investigated  in this study, and the results are equally 
compatible with it being a DC or a macrophage. However, 
numerous studies suggest  that DC, and not macrophages, 
are the main APC population for the priming of class II-re- 
stricted  T  cells in vivo (50, 51) and in vitro (52, 53). 
The outcome of the experimental protocol described here 
could have been influenced by the choice of immunization 
procedure, e.g., soluble vs. particulate Ag, and by the assay 
chosen to test T cel] function. For example, particulate Ag 
(such as the alum precipitate used here) may not be taken 
up ef~ciently by nonphagocytic calls such as B calls, while 
soluble Ag might. Also, specific  T cell subpopulations might 
respond  suboptimally  to Ag presented on B ceils; analysis 
of such T cell subpopulations would, of course, fail to reveal 
differences  between priming in the presence or in the absence 
of B cells. Neither of these possibilities appears to apply to 
the present study. Production of specific antibodies  of the 
IgG isotype suggests that B cells had been exposed to Ag adequately, and were able to interact with T cells to receive 
cognate help. This implies B cells were sufficiently activated 
(even in the absence of bacterial components in the adjuvant) 
to be able to act as effective APC for T cells. Also, although 
a complete characterization of the lymphokines produced by 
T  cells was not attempted, analysis  of two different lym- 
phokines, II.-2 and II.3,  produced by partially overlapping 
subsets of T  cells (42),  failed to reveal differences related to 
the presence or absence orb cells. Therefore, the finding that 
B cells are not required for the induction of a primary T cell 
response does not appear to be simply a consequence of the 
experimental system used, but might also apply to the pre- 
sentation of other types of Ag, entering the organism via 
different routes. 
Previous reports have used mice depleted of B cells by chronic 
anti-/~ treatment (12-14, 16), or lacking expression of a specific 
class II molecule on B cells (54),  to show that B cells are 
required for the generation of lymph node proliferative T 
cell responses after in vivo Ag immunization. It is not clear 
why no or suboptimal T cell responses were detected in such 
studies, as opposed to the normal responses reported here. 
One possibility is that, as different readout systems were used, 
B cells might be required for the generation of proliferative 
but not lymphokine responses. Other authors (55) have, how- 
ever, reported that SCID mice reconstituted with syngeneic 
thymocytes could generate normal proliferative and II.-2 re- 
sponses after in vivo immunization in the absence of B cells; 
preliminary results showed that also in our case T cells from 
SCID  mice reconstituted only with  T  cells  were able to 
proliferate in vitro, and could generate long-term Ag-specific 
T  cell lines.  Residual B cell contamination is also probably 
not responsible for the ability of reconstituted SCID mice 
to generate T cell responses.  By FACS  |  staining, contamina- 
tion by donor or host type B cells in the spleen or lymph 
nodes of SCID mice reconstituted only with T cells was below 
detection, therefore at a level lower or comparable to the level 
detected in anti-/~-treated mice (12, 14). The very low levels 
of serum Ig detected in SCID mice reconstituted with T cells 
only (and in noninjected SCIDs),  mostly of the #  isotype 
and that failed to show Ag-specific activity, could possibly 
be due to leaky B cells, described to occur in the peritoneal 
cavity of older SCID mice (56).  Due to their distribution 
these ceils are, however, unlikely to contribute to responses 
taking place in the lymph node. Lastly, it is possible that Ag 
presented by DC is limiting in anti-/~ but not in SCID mice. 
The low number ofT cells present in SCID mice would allow 
any T  cell access to Ag presented on DC;  the same might 
not be the case in anti-~ mice, where the ratio of T  cells 
to DC is much higher. Expansion of specific T cells on Ag- 
loaded B cells would then be required for detection of a re- 
sponse in anti-/~ mice, but not in SCIDs. However, the low 
number of Ag-specific B cells that are able to take up and 
present efficiently to T cells, as compared with the much larger 
number of DC, makes this possibility rather unlikely. Fur- 
ther experiments making use of different experimental models 
(57,  58)  should help to resolve this issue. 
The experiments discussed so far establish that B lympho- 
cytes are not required for the initiation of a primary T  cell 
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response in vivo; however, they do not exclude that B cells 
might be able to present direcdy to T cells when in the ab- 
sence of the dominant APC population, DC.  To test this 
possibility, the MHC restriction of Ag-specific T cells in the 
SCID chimeras was determined. B cells in these mice were 
the only cells bearing I-Ab; therefore, any I-Ab-restricted, 
Ag-specific T cells could have been primed only on B cells. 
The results obtained showed quite dearly that naive T cells 
were primed by Ag presented on DC but not on B cells; 
however, B cells were able to reactivate previously primed 
T  cells. The difference in the ability of B cells to elicit sec- 
ondary but not primary Ag-specific T cell responses in vivo 
was not due to a different degree of reconstitution of the 
B cell compartment in the two groups of mice, as the ratio 
orB vs. T cells was actually higher in mice reconstituted with 
naive rather than primed T  cells; nor was it related to the 
presence of Ag-specific B cells, as naive T ceils could not be 
primed by B cells even when the B cells were from Ag-primed 
donors. Production of specific antibodies showed that B cells 
had been loaded with Ag and were able to interact produc- 
tively with T cells. Also, H-2~-restricted responses could be 
demonstrated in SCID mice reconstituted with naive T ceils 
and immunized by injection of Ag-pulsed DC  from cB6 
(H-2  a  x  H-2  b) donors (not shown), showing that H-2  b is 
not intrinsically worse than H-2  d in presenting Ag, and that 
T  cells were able to use the I-A  b restriction dement if the 
appropriate APC were present. Therefore, we interpret our 
results as indicating an absolute incapacity orB cells to stimu- 
late primary Ag-specific T cell responses in vivo. Results con- 
sistent with these fndings have also been reported using in 
vivo systems by Sprent (59) in the mouse and Lassila et al. 
(17) in the chicken; and in vitro by Inaba and Steinman (52, 
53).  In  all  cases  B  cells  were shown  to  be  inefficient in 
stimulating resting T  cells, but able to receive help by al- 
ready activated T  cells. 
Unlike resting B cells, activated B cells have been reported 
to be very efficient APC in vitro (60, 61), and express adhe- 
sion molecules that are absent in resting B cells (62). If, how- 
ever, B cells require a T  cell-derived signal to be activated 
and become efficient APC (63, 64), failure to induce specific 
T  cells could in turn prevent the activation of B cells into 
APC potentially able to prime other T cells. The experimental 
design used in this study allowed us to test this possibility. 
After activation by H-2a-restricted T  cells, B cells in SCID 
mice expressed high levels of class II (not shown) and pro- 
duced antibodies. Once activated they should theoretically 
have been able to prime T cells, such as H-2b-restricted  ones. 
As  no H-2b-restricted T  cells  could be demonstrated, we 
conclude that B cells, either resting or activated, are unable 
to prime naive T  cells. Most likely, the inability of B cells 
to present Ag to naive T cells is due to their lack of specific 
adhesion molecules (3, 65). Memory T cells are reported to 
express higher levels of adhesion molecules than naive T cells 
(3); such high levels render them more easily triggered when 
exposed to  APC  expressing  the correct  Ag ligand.  In  a 
reciprocal fashion, expression of higher levels of adhesion mol- 
ecules, or of additional ones, could render DC more efficient 
APC than B cells. B7/CD28 is one adhesion molecule/ligand 
In Vivo pair whose importance in APC/T cell interactions has re- 
cently been recognized (66): simultaneous engagement of TCR 
and CD28 leads to increased T  cell proliferation and lym- 
phokine production (67, 68), and can override tolerance in- 
duction by APC that lack a costimulatory signal (69,  70). 
The ligand for CD28,  BB1/B7, is expressed on DC (71), 
IFN-'y-activated macrophages (72), and on activated but not 
resting B cells (62); its expression may transiently follow T-B 
cell cognate interaction (73). If coengagement of CD28 and 
TCR were the only signals required for priming naive T cells, 
activated B cells would be expected to prime T  cells. Our 
results suggest that this is not the case and that B cells, either 
resting or activated,  are truly unable to prime T cells. Our 
results do not address the possibility that B cells, if unable 
to prime, would rather deliver a negative signal resulting in 
the functional inactivation of naive T  cells. Another more 
trivial possibility is that the compartmentalization of cells 
in lymphoid organs may favor naive T cells encountering Ag 
on DC but not on B cells. Only after T cells have been stimu- 
lated by Ag on APC in the T cell area of the lymph node 
would they migrate to the B cell areas to deliver help through 
recognition of Ag presented on B cells. If this is the case, 
it could represent (under physiological conditions of Ag dis- 
tribution and presentation) a way to prevent encounter of 
naive T  and B cells that, as recently reported, could induce 
tolerance in naive T  cells (74). 
Previous studies have reported that activated but not resting 
B cells are able to prime normal T cells to alloresponses in 
vitro (75, 76). Since peripheral T cells were used as a source 
of responding T cells, and since such T cell preparations com- 
prise not only naive T cells but also a significant proportion 
of Ag-experienced T  cells, it is quite likely that the T  cell 
responses elicited by B cells were, like in the present study, 
due to Ag-experienced T  cells. This also predicts that any 
T  cell response in an adult animal, where a proportion of 
the peripheral T cell pool is Ag experienced,  would include 
recall of crossreactive memory T cells, and may involve Ag 
presentation by B cells. Evidence that such a mechanism may 
indeed take place in vivo was obtained in experiments in which 
SCID mice were reconstituted with high density splenic T+ B 
cells from nonimmunized mice, and found to be able to 
generate low numbers of H-2b-restricted T cells after Ag im- 
munization (not shown). An analogous mechanism could 
explain a recent study where induction of lymph node prolifer- 
ative responses was reported to follow the induction of acti- 
vated B cells in vivo (77): suboptimal priming on DC would 
only be revealed after expansion on Ag-specific B cells. 
The results reported in this paper do not allow us to dis- 
criminate whether Ag presented by B cells to previously ac- 
tivated T cells either induces proliferation and clonal expan- 
sion of such T cells, or T cells are "recalled" to an effector 
phase in the absence of any proliferation, or are simply res- 
cued from being eliminated. Whatever the mechanism, the 
ability orB cells to elicit secondary T cell responses may con- 
stitute a mechanism by which T cell memory is maintained. 
Previous studies have suggested that B cell memory could 
be maintained by the continuous exposure to Ag (78) stored 
on follicular dendritic cells in lymph node follicles (79, 80). 
B cells, which were shown to be able to take up, internalize, 
and present Ag stored on follicular dendritic cells (81), could 
therefore act as APC for the maintenance of memory T cells. 
Our results show that B cells are unable to prime naive 
T  cells in vivo, but are capable of eliciting Ag-specific re- 
sponses in previously primed T cells. This latter property of 
B cells might be especially  important in adult animals in which, 
due to thymus involution, a relevant fraction of the periph- 
eral T cell pool is constituted by Ag-experienced cells. This 
finding may lend some support to the hypothesis that selec- 
tive in vivo activation  of specific T  cell  subpopulations, 
producing distinct patterns of lymphokines, correlates with 
the type of APC participating in the response in vivo (45, 
82, 83).  T  cells receiving signals through the engagement 
of different sets of adhesion molecules, whose ligands are 
differentially expressed by DC and by B cells, would be driven 
to production of different lymphokines, thus marking the 
response as Thl or Th2. This could possibly constitute a mech- 
anism for the regulation of the immune response. 
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